Combined Modulation of Tumor Metabolism by Metformin and Diclofenac in Glioma

URN to cite this document:: urn:nbn:de:bvb:355-epub-378943
DOI to cite this document:: 10.5283/epub.37894

Gerthofer, V. ; Kreutz, Marina ; Renner, Kathrin ; Jachnik, Birgit ; Dettmer, Katja ; Oefner, Peter J. ; Riemenschneider, Markus J. ; Proescholdt, Martin A. ; Vollmann-Zwerenz, Arabel ; Hau, Peter

; Seliger, Corinna

Preview

License: Creative Commons Attribution 3.0
PDF
(1MB)

Date of publication of this fulltext: 02 Nov 2018 13:30

Alternative links to fulltext:Pubmed DOI Publisher

Details

Preview

Indexed in

Export bibliographical data

Abstract

Glioblastoma remains a fatal diagnosis. Previous research has shown that metformin, which is an inhibitor of complex I of the respiratory chain, may inhibit some brain tumor initiating cells (BTICs), albeit at dosages that are too high for clinical use. Here, we explored whether a combined treatment of metformin and diclofenac, which is a non-steroidal anti-inflammatory drug (NSAID) shown to ...